Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No no no....You still don't get it. Sure there's plenty of good people involved but they don't care about shareholders. Powers should but...NWBO is out of money and more dilution sure to come. Reverse split in the air. DCVax may do some good eventually but CURRENT shareholders will likely not see a dime.
Funny, Woodford seems to feel mislead. I guess he wasn't really following though. Lol.
Correct. Take a look at Peregrine, CYTR, many others...All the same game plan.
What was weird?
Actually over the years I've found with boards like this expressing overwhelming positivity with just a few doubters, that the doubters are almost always right! ...I suppose it could have to do with pushing the doubters away too where the board is unbalanced??
Precisely. And people running these schemes aren't typically in the habit of giving money back. Enter the Reverse Split; Why waste all that fine talent and experience when they can do it again and again and again?
"I also applaud her resolute to see the trial to the very end to gain as much and as many data as possible in a blinded way. "
Yes, just as Woodford and his $100 plus million did. What if she's just collecting a nice salary and not really doing much at all (maybe lots more with Cognate?) except finding funds to for the university?
Actually that was a trick question! I think they'll be antother awful cash raise but we may never see results.
It's one thing to wait but it's an entirely other thing to wait while CEO, CFO, COB, Bookkeeper Powers, does horrendous cash raises. Think!
Of course it does. There's no excuse to exclude interim analysis. At the very least just for ongoing biomarker data.
Keep them in the dark while ever lower cash raises totals nice sums.
In these schemes it's the universities drawing in much need cash to conduct research via the "partner" sponsor's shareholders. So I fail to see how the university is the one being scammed??
As a possibility, what if the university isn't following trial protocol and tiny-under resourced-Northwest looks the the other way? You could imagine where this might lead and how shareholders would find themselves lost in the dark.
$30,000 of hot action so far this morning! Lol.
Would've made a nice PR, if it really meant anything. Too bad, I guess Powers is still down with the flu.
...Many sites show the DCVax study was last verified in 2014 so...
I bet that video is from 2013. There's a later 2016 video where she talks about Optune therapy. No mention of DCVax. You can tell by how she's talking the DCVax trial was over a while ago but she's only interested in the data.
Can't Toucan Capitaless step in the save them?
Well said, thank you.
Hmm, yes I see. I did enough reading myself. Seems Toucan got its head handed to it betting on Stem cells and NanoTech. Both funds appear closed.
Toucan and Powers reminds me very much of the Roswell Capital story and the owner who "saved" the small biotech, Techniclone. In hindsight, one really has to wonder who saved who?
Can someone please tell me why if Toucan is doing such good work did NWBO just do such a lousy cash raise? Thanks.
Toucan Capital Fund II, L.P. is a $120 million venture capital fund (SBIC) focused on seed and early-stage life science and advanced technology investments. Toucan Capital Corp. launched its first fund in 1997 and began investing its current fund in August of 2001. Toucan invests nationwide and is one of the largest and most active venture capital funds in seed and early-stage life science. Toucan has also been an early investor in nanotechnology. Toucan is especially active in the mid-Atlantic region, one of the richest markets in the country for life science and certain advanced technologies, and a market that has generally been underserved by venture capital.
Toucan usually serves as the lead or co-lead investor and takes an active, hands-on role working closely with company management to help build its portfolio companies. For example, Toucan often assists its portfolio companies in building and strengthening their intellectual property base, formulating partnering and regulatory strategies, and ensuring that commercialization and payment/reimbursement issues are addressed from the earliest stages of the company's development.
Can anyone please advise me on the CEO's performance record with her company, Toucan Capital?
Thanks.
Why doubt it? Happens all the time. Just look at the pay to play deals Peregrine made over its history.
Do you think Woodford will just sit back and watch that happen?
Can they somehow pool them with PPHM?
With the SEC lurking do you really think she can do another offering?
Funny, I though good governance mattered to assure those who invest (shareholders) are protected from malfeasance and assured proper fiduciary duty. But that's me.
Do you really want to see ineffective leadership with poor corporate governance scores, be rewarded in tax dollars?
I remain, as ever, in your caring arms
I am confident in your nourishment
Though time marches on for us, not so much for you
And yet hope springs eternal
My trust in you is undeniable
Your track record unblemished in the silence
In the sacrament of holy matrimony we stand firm
For no man or federal agency can come between us
I am bound to you, oh my Linda!
Daily affirmation or lowered expectations?
"On the road" is the same as "On track"....We all know how that often goes.
I guess "most people" couldn't drive the stock off its lows. Lol.
Not an SEC Update? What about something from Woodford on litigation?
Over two years gone by and nothing. Feuerstein also recently said there's an SEC investigation, did he not?
Are you calling the good Dr. Liau a Liar? How lame! Where's Linda and Les?
Yep, no real quote, as suspected.
Yes, until it doesn't and you're left wondering why the vaccine might've worked but shareholders are left holding ashes.
Show me this Woodford quote please.
"Top line data". You and I know how that goes don't we?
Yes, they're probably sitting on it, destroying shareholder equity and cancer victims hopes. Crazy.
Wrong. She gave away nearly a third of shareholder equity just a short time ago. Shareholder should be livid if good news on the horizon but not you all.